Sandra A. Milligan,

Chair, Fellows of DIA
Head of Regulatory Affairs and Safety
Merck Research Laboratories

Dr. Milligan currently serves as Senior Vice President and Head of Global Regulatory Affairs and Clinical Safety at Merck, consisting of the global Regulatory, Safety, and Chemistry, Manufacturing and Control functions of Merck Research Laboratories. Previously serving as Vice President, Global Regulatory, Immunology, Respiratory, Infectious Diseases and Ophthalmology for Genentech/Roche, she developed and directed global strategic regulatory plans to facilitate and optimize product development, regulatory approval, and commercialization.

Previous to Genentech/Roche, Dr. Milligan served at Amgen for almost ten years in various roles, including Global Regulatory Therapeutic Area Head for the Bone franchise; Head of Regulatory Communications Strategy & Operations; and as Senior Counsel for the Development, Regulatory & Compliance Law Group, where she provided strategy for development, regulatory, and safety groups.

In addition to serving on the DIA Board of Directors and as the Immediate Past President, Dr. Milligan served as the DIA Board of Directors President from July 2015 – June 2016, as Program Chair for the 2013 DIA Annual Meeting in Boston, as well as co-chair of the Public Policy/Health Care Compliance/Regulatory Law Annual Meeting track. Dr. Milligan is a graduate of The George Washington University School of Medicine and the Georgetown University Law Center.